triple-negative breast cancer

AstraZeneca stands by Truqap despite surprise breast cancer flop

AstraZeneca's Truqap was through and through a bust in triple-negative breast cancer, but a company exec argued the failure was probably a one-off.

Angus Liu Sep 13, 2024 10:00am

topic report

start race starting block runners go advance

Merck, AstraZeneca, Gilead: The race for supremacy in an ADC field

Aug 2, 2024 4:00pm

AZ's Truqap came up short in triple-negative breast cancer study

Jun 18, 2024 9:09am

Graham

Roche's new pharma chief talks Tecentriq in early cancers

Apr 26, 2023 9:17am

VMLYR and Gileads AI-enabled artist

VMLY&R, Gilead use AI to turn patient testimonies into paintings

Feb 16, 2023 10:15am

View of Mt Everest from Base Camp

Gilead gains Trodelvy's Asian rights in $455M deal

Aug 16, 2022 10:35am